Browse Category

Stock Market 24 May 2026

Medline’s $2.7 Billion Stock Sale Just Put Its IPO Buzz Back on Trial

Medline’s $2.7 Billion Stock Sale Just Put Its IPO Buzz Back on Trial

Medline Inc.’s next test comes before the opening bell after a holiday weekend: whether investors keep the stock near a $37 secondary-offering price after selling shareholders upsized the deal to 72.55 million Class A shares, with a 30-day option for underwriters to buy 10.88 million more. Medline said it will not sell shares or receive proceeds, and expects the offering to close on May 28.
24 May 2026
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 94 / 100
#2 BUY

AerCap

NYSE: AER 92 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 89 / 100
#4 BUY IN TRANCHES

Lennox

NYSE: LII 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.